ASP-0819   Click here for help

GtoPdb Ligand ID: 12646

Synonyms: ASP0819 | Example 10 [WO2014196644A1]
Compound class: Synthetic organic
Comment: ASP-0819 is a KCa3.1 channel activator [2], that is in clinical development for analgesic potential. It is proposed that ASP-0819's action at KCa3.1 channels, reverses the abnormal signal transmission in primary sensory afferent nerves that underlies an aberrant sensation of pain in a range of conditions.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 5
Hydrogen bond donors 2
Rotatable bonds 6
Topological polar surface area 87.1
Molecular weight 471.01
XLogP 2.8
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CC1=C(C2=CC(=C(C=C2)N3CCO[C@H](CNC4CCC4)C3)C(=O)O)C5=C(C=C(C=C5)Cl)S1
Isomeric SMILES CC1=C(C2=C(S1)C=C(Cl)C=C2)C3=CC=C(N4CCO[C@H](CNC5CCC5)C4)C(=C3)C(O)=O
InChI InChI=1S/C25H27ClN2O3S/c1-15-24(20-7-6-17(26)12-23(20)32-15)16-5-8-22(21(11-16)25(29)30)28-9-10-31-19(14-28)13-27-18-3-2-4-18/h5-8,11-12,18-19,27H,2-4,9-10,13-14H2,1H3,(H,29,30)/t19-/m1/s1
InChI Key IOWRHVVSRLGDKK-LJQANCHMSA-N
References
1. Arnold LM, Blauwet MB, Tracy K, Cai N, Walzer M, Blahunka P, Marek GJ. (2020)
Efficacy and Safety of ASP0819 in Patients with Fibromyalgia: Results of a Proof-of-Concept, Randomized, Double-Blind, Placebo-Controlled Trial.
J Pain Res, 13: 3355-3369. [PMID:33328761]
2. Ishihara T, Ikigai K, Kuriwaki I, Hisamichi H, Takeshita N, Takezawa R. (2014)
Benzothiophene compound.
Patent number: WO2014196644A1. Assignee: Astellas Pharma Inc.. Priority date: 16/06/2014. Publication date: 11/12/2014.